Coronavirus disease 2019 (COVID-19) has spread rapidly around the world since the outbreak in Wuhan, Hubei Province, China in 2019. COVID-19 is an infection caused by the novel coronavirus SARS-CoV-2.
In case 1, there were low white blood cells. In case 2, mild lung involvement was observed on his chest computed tomography. In case 3, high levels of ferritin and procalcitonin in blood parameters were found remarkably. During the COVID-19 pandemic, symptoms and laboratory parameters differ from person to person. Timely diagnosis, isolation and initiation of necessary treatments are necessary to significantly reduce the risk of disease transmission. Several biomarkers have been identified that could potentially assist risk classification models to predict severe and deadly COVID-19.
Coronavirus disease 2019 (COVID-19) has spread rapidly around the world since the outbreak in Wuhan, Hubei Province, China in 2019. COVID-19 is an infection caused by the novel coronavirus SARS-CoV-2.
In case 1, there were low white blood cells. In case 2, mild lung involvement was observed on his chest computed tomography. In case 3, high levels of ferritin and procalcitonin in blood parameters were found remarkably. During the COVID-19 pandemic, symptoms and laboratory parameters differ from person to person. Timely diagnosis, isolation and initiation of necessary treatments are necessary to significantly reduce the risk of disease transmission. Several biomarkers have been identified that could potentially assist risk classification models to predict severe and deadly COVID-19.
Birincil Dil | İngilizce |
---|---|
Konular | Sağlık Kurumları Yönetimi |
Bölüm | Olgu Sunumu |
Yazarlar | |
Yayımlanma Tarihi | 25 Şubat 2022 |
Yayımlandığı Sayı | Yıl 2022 Cilt: 8 Sayı: 1 |